Every figure below is transcribed from published literature (peptideprotocolportal.com, compiled 2026-09-29). None of it is a recommendation, a protocol, or a target, and none of it was written here. Whether any of it applies to a person is a question for a licensed clinician — who this is for explains why.
What the source says not to do
Quoted word for word from the notes column. Nothing here is paraphrased, and nothing has been added.
- Single dose not to exceed 250mg
- IM single dose not to exceed 250mg.
All 3 presentations, as reported
The source lists this compound once per vial size. All of them are shown rather than one chosen for you, because the ranges differ between them.
| Vial | Dose | Frequency | Route |
|---|---|---|---|
| 100mg | 50-100mg | Daily or 2x/week | IM |
| 500mg | 50-150mg | Daily or 2x/week | IM |
| 1,000mg | 100-250mg | Daily or 2x/week | IM/IV |
The source's own notes
Reproduced in full, including the parts that are description rather than caution. Trimming this column for layout would remove its harm-reduction payload.
Single dose not to exceed 250mg
High-volume vial for IV drip protocols - dilute in NS/D5W. IM single dose not to exceed 250mg. IV: 500-1,000mg over 2-4 hrs
Before anything else
A compound's paperwork is the part you can actually verify. Reading a Certificate of Analysis and what a COA cannot tell you cover both halves of that, and inspecting a vial on arrival covers what to check before a vial is opened at all.